| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Point/Counterpoint |
A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians1
Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115 [L-L. X., G. L., D. P. M., W. Z., L. S., D. C. C.], and Thoracic Surgery Unit, Department of Surgery [J. C. W.], Pulmonary and Critical Unit Medicine [D. C. C.] and Cancer Center, Division of Hematology-Oncology [G. L., T. J. L.], the Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
Abstract
The myeloperoxidase (MPO) G-to-A substitution polymorphism in the promoter region of the MPO gene has been associated with a 40–70% reduction in lung cancer risk in several studies, although a recent nested case-control study disputes these findings. MPO is involved in the activation of a number of procarcinogens, including benzo(a)pyrene. The variant A allele has been shown to reduce MPO mRNA expression, thus potentially decreasing carcinogen activation. To confirm results from smaller studies, we evaluated this MPO polymorphism in 988 incident Caucasian lung cancer cases and 1128 controls. Logistic regression evaluated the association between MPO genotype and lung cancer risk, adjusting for age, gender, smoking status, time since quitting smoking, and pack-years of smoking. In the controls, the A allele frequency was 21%, and genotype distribution was in the Hardy-Weinberg equilibrium. Compared with the wild-type G/G genotype, the adjusted odds ratios for the A/A and A/G genotypes were 1.15 (95% confidence interval 0.7–1.9, P > 0.2) and 1.03 (95% confidence interval 0.8–1.3, P > 0.20), respectively. A similar lack of association was seen in analyses stratified by smoking status, median age, a number of smoking variables, disease stage, tumor grade, and histological subtype. These findings are in contrast with earlier studies suggesting a protective effect of carrying the variant A allele.
This article has been cited by other articles:
|
|
 |
|
  J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort Carcinogenesis, May 1, 2008; 29(5): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yang, C. B. Ambrosone, C.-C. Hong, J. Ahn, C. Rodriguez, M. J. Thun, and E. E. Calle Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer Carcinogenesis, June 1, 2007; 28(6): 1247 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Schwartz, G. M. Prysak, C. H. Bock, and M. L. Cote The molecular epidemiology of lung cancer Carcinogenesis, March 1, 2007; 28(3): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhu, L. Yang, B. Zhou, R. Yu, N. Tang, and B. Wang Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study Carcinogenesis, December 1, 2006; 27(12): 2491 - 2496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten Neutrophils and respiratory tract DNA damage and mutagenesis: a review Mutagenesis, July 1, 2006; 21(4): 225 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Larsen, M. L. Colosimo, I. A. Yang, R. Bowman, P. V. Zimmerman, and K. M. Fong CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung Carcinogenesis, March 1, 2006; 27(3): 525 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer Cancer Res., February 1, 2005; 65(3): 1105 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, P. D. Josephy, and C. B. Ambrosone Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk Cancer Res., October 15, 2004; 64(20): 7634 - 7639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Schwartz Genetic Predisposition to Lung Cancer Chest, May 1, 2004; 125(5_suppl): 86S - 89S. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, M. Chen, H. Yagi, D. M. Jerina, and S. G. Carmella r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in Human Urine: A Potential Biomarker for Assessing Polycyclic Aromatic Hydrocarbon Metabolic Activation Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dally, H. Bartsch, and A. Risch Correspondence re: Feyler et al., Point: Myeloperoxidase -463G -> A Polymorphism and Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The Myeloperoxidase -463G -> A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians. 11: 1555-1559, 2002 Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 683 - 683. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
